Migraine headaches: a historical prospective, a glimpse into the future, and migraine epidemiology.
Unger
Jeff
J
Chino Medical Group Diabetes and Headache Intervention Center, Quadrant Medical Education, CA, USA.
D001549:Benzamides / Q000627:therapeutic use; D001578:Benzopyrans / Q000627:therapeutic use; D015740:Calcitonin Gene-Related Peptide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004878:Ergotamine / Q000627:therapeutic use; D014943:Global Health; D006801:Humans; D015994:Incidence; D007189:Indans / Q000627:therapeutic use; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology* / Q000517:prevention & control; D010879:Piperazines / Q000627:therapeutic use; D015995:Prevalence; D011446:Prospective Studies; D011799:Quinazolines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013141:Spiro Compounds / Q000627:therapeutic use; D018170:Sumatriptan / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D001549:Benzamides; D001578:Benzopyrans; D007189:Indans; D010879:Piperazines; D011799:Quinazolines; D013141:Spiro Compounds; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; C495412:spiro((1,3-diazacyclopent-1-ene)-5 : 2'-(4',5'-dimethylindan)) fumarate; C118706:tonabersat; D018170:Sumatriptan; D015740:Calcitonin Gene-Related Peptide; D004878:Ergotamine; C406305:olcegepant